Global Stroke Management Market Overview 2024: Size, Growth Rate, and Segments

The stroke management global market report 2024  from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Stroke Management Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size –
The stroke management market size has grown strongly in recent years. It will grow from $36.94 billion in 2023 to $39.98 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%.  The  growth in the historic period can be attributed to thrombolytic therapies, stroke prevention initiatives, rehabilitation techniques, telemedicine in stroke care, collaborative stroke networks.

The stroke management market size is expected to see strong growth in the next few years. It will grow to $52.89 billion in 2028 at a compound annual growth rate (CAGR) of 7.2%.  The growth in the forecast period can be attributed to emergence of neuroprotective therapies, artificial intelligence in stroke diagnosis, personalized medicine approaches, expanding access to acute care, global stroke care standardization. Major trends in the forecast period include advancements in medical imaging technology, telemedicine and remote monitoring, focus on preventive care and risk factor management, neuroprotective therapies and drug innovations, collaboration and multidisciplinary approaches.

Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/stroke-management-global-market-report

Scope Of Stroke Management Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Stroke Management Market Overview

Market Drivers –
The increasing incidence of chronic diseases is expected to propel the growth of the stroke management market going forward. Chronic diseases refer to a problem that persists for a year or longer and impedes everyday activities, necessitates continuing medical care, or both. Stroke management assists patients suffering from various chronic diseases, such as cancer and cardiovascular diseases, by providing a timely focus on preventive, care, and support requirements through patient education and empowerment as well as the creation of care delivery models that integrate primary and secondary care. For instance, in January 2023, according to the National Library of Medicine a US-based biomedical library highlights, there will be 142.66 million people aged 50 and older in 2050 who have at least one chronic disease, up from 71.522 million in 2020, a 99.5% rise. Therefore, the increasing incidence of chronic diseases is driving the growth of the stroke management market going forward.

Market Trends –
Technological advancements are a key trend gaining popularity in the stroke management market. Companies operating in the stroke management market are adopting new technologies to sustain their position in the market. For instance, in November 2021, Qure.ai, an India-based artificial intelligence solution company, launched an AI stroke management platform to enable the remote diagnosis of emergency stroke cases. The AI imaging solution developed by the startup, called qER, powers the Qure.ai Stroke Management Platform. It is a triage and notification tool approved by the US FDA under 510(k) that can identify and quantify up to 12 abnormalities on head CT scans, including bleed, fracture, mass effect, and midline displacement. It aids in the early detection of stroke. Neurologists, radiologists, and neurosurgeons are among the stroke stakeholders who can examine clinical and imaging data using a companion mobile app for the stroke management system. It creates PDF reports and allows the viewing of DICOM files. Clinicians may share photos and reports, alter AI results, and more using the app.

The stroke management market covered in this report is segmented –
1) By Product Type: Diagnostics, Drug Therapy Products, Interventional Stroke Management Systems
2) By Application: Ischemic Stroke, Hemorrhagic Stroke
3) By End-User: Hospitals, Clinics, Ambulatory Surgery Centers, Diagnostic Centers, Retail Pharmacies, Online Pharmacies, Other End Users

Get an inside scoop of the stroke management market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=9988&type=smp

Regional Insights –
North America was the largest region in the stroke management market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global stroke management market report during the forecast period. The regions covered in the stroke management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Key Companies –
Major companies operating in the stroke management market report are GE HealthCare Technologies Inc., Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, B Braun Melsungen AG, Bristol Myers Squibb Co., Cardinal Health Inc., Glaxosmithkline Plc, Siemens AG, Merck And Co. Inc., Asahi Intech Co. Ltd., Johnson & Johnson, Penumbra Inc., Teleflex Inc., Stryker Corporation, Biogen Inc., Bayer AG, Philips Healthcare, AstraZeneca Plc., F. Hoffmann-la Roche, Novartis AG, Takeda Pharmaceutical Company Ltd., Sanofi SA, Daiichi Sankyo Company Limited, Boehringer Ingelheim International GmbH, Pfizer Inc., Integer Holdings Corporation

Table of Contents
1. Executive Summary
2. Stroke Management Market Report Structure
3. Stroke Management Market Trends And Strategies
4. Stroke Management Market – Macro Economic Scenario
5. Stroke Management Market Size And Growth
…..
27. Stroke Management Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Leave a Reply

Your email address will not be published. Required fields are marked *